Biocom California and KoreaBIO Sign MOU to Strengthen US-Korea Life Science Collaboration

Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade association which seeks to solid...

May 13, 2025 | Tuesday | News
Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Strengthening Global IP Portfolio for Autoimmune Drug

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals", "Conduit" or the “Company”) today announces that the Korean Intellectu...

May 12, 2025 | Monday | News
LENZ Therapeutics and Lotus Pharmaceutical Ink $125M Licensing Deal to Commercialize LNZ100 for Presbyopia in Asia

LENZ Therapeutics, Inc.  and Lotus Pharmaceutical Co., Ltd. y announced an exclusive license and commercialization agreement for Lotus to commercial...

May 12, 2025 | Monday | News
PL BioScience and DewCell Introduce First Artificial Human Platelet Lysate Enabling Scalable Xeno-Free Cell Therapy Manufacturing

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceutical...

May 09, 2025 | Friday | News
Qosina Partners with Sealed Air to Expand Bioprocessing Portfolio with NEXCEL® BIO1250 High-Performance Bag Film

Qosina, a global leader in the distribution of single-use medical and biopharmaceutical components, is proud to announce a new strategic partnership with...

May 09, 2025 | Friday | News
GeneFab and RegCell Unite to Accelerate U.S. Clinical Manufacturing of Next-Gen Treg Therapies

GeneFab, a next-generation cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCe...

May 08, 2025 | Thursday | News
Moleculin Secures Two New U.S. Patents for Annamycin, Expanding IP Protection Through 2040

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfoli...

May 06, 2025 | Tuesday | News
Roquette Announces New Organizational Structure Following IFF Pharma Solutions Acquisition

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces today a new organizati...

May 05, 2025 | Monday | News
Inventiva CEO Frederic Cren Confirms Completion of NATiV3 Enrollment, Eyes Approval Path for Lanifibranor in MASH

Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic...

May 05, 2025 | Monday | Company results
CEO Chris Cargill Marks One-Year Transformation Milestone as Nxera Pharma Reports Strong Q1 2025 Progress

Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated resu...

May 05, 2025 | Monday | Company results
Roquette Completes Acquisition of IFF Pharma Solutions, Strengthens Global Pharma Leadership

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces the successful complet...

May 01, 2025 | Thursday | News
Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, PhD, MBA, Chief Operating Officer of Vector BioMed, shares how the company is reimagining...

April 25, 2025 | Friday | Interview
Sanofi CEO Paul Hudson Confident in 2025 Growth Trajectory as Q1 Sales Climb 9.7% and Pipeline Delivers Six Approvals

CEO Paul Hudson: Confidence in Full-Year Outlook Paul Hudson, Chief Executive Officer: “We had a strong start in 2025 with sales growth of 9.7%, b...

April 24, 2025 | Thursday | Company results
Argent BioPharma Enters German Market with CannEpil® and CogniCann® Following Regulatory Approval

Argent BioPharma Ltd. , a clinical-stage biopharmaceutical company specializing in neuroimmune therapies, is pleased to announce its official entry into th...

April 24, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close